Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA

Clinical trial NCT02064725 · UNKNOWN

Trial details

NCT number: NCT02064725
Sponsor: Kevelt AS
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Persistent Endometrial Carcinoma

Start date: 2014-09-01
Primary completion: 2018-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.